First Report in the Literature of Biopsy-Proven Noncollapsing Focal Segmental Glomerulosclerosis Relapse in a Second Renal Transplant Presenting With Thrombotic Microangiopathy: A Case Report
| Autor: | Alvaro Torres-De-Rueda, María Dolores Navarro-Cabello, Pedro Rosa-Guerrero, Marisa Agüera-Morales, Alberto Rodríguez-Benot, Fernando Leiva-Cepas |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Male
medicine.medical_specialty Thrombotic microangiopathy Biopsy medicine.medical_treatment Urology Kidney urologic and male genital diseases Young Adult Focal segmental glomerulosclerosis Recurrence Renal Dialysis medicine Humans Dialysis Transplantation Glomerulosclerosis Focal Segmental Thrombotic Microangiopathies urogenital system Primary Focal Segmental Glomerulosclerosis business.industry Acute kidney injury Eculizumab medicine.disease Kidney Transplantation female genital diseases and pregnancy complications Surgery Hemodialysis business Nephrotic syndrome medicine.drug |
| Zdroj: | Transplantation Proceedings. 53:2747-2750 |
| ISSN: | 0041-1345 |
| Popis: | Primary focal segmental glomerulosclerosis (FSGS) is a podocytopathy with an irregular response to immunosuppressive therapies. FSGS relapse occurs in 30% to 80% of kidney grafts, and poor survival outcomes include large proteinuria and the nephrotic syndrome's cardinal clinical features. Thrombotic microangiopathy (TMA) is caused by endothelial injury due to complement dysregulation including acute kidney injury, proteinuria, and severe hypertension common renal presentations. Both pathologies have well-described genetic forms, but their relationship remains uncertain. FSGS lesions can be found in kidney biopsy specimens in patients with TMA, and TMA has been reported in patients with collapsing glomerulopathy. However, this combination has not been clearly described in renal transplant recipients. We present the case of a 22-year-old man who received his second kidney allograft and developed an early graft disfunction with nephrotic syndrome and clinical TMA. His background was remarkable for primary, biopsy-confirmed FSGS in childhood, and he started hemodialysis in 2006 and received a living donor kidney graft the same year. He presented with a FSGS relapse with malignant hypertension and seizures in the first posttransplant month and had an irregular response to plasma exchange and rituximab, and dialysis was reinitiated 10 years later. A total of 3 biopsies were performed after his second kidney transplant showing the evolution of a FSGS relapse with histologic and clinical TMA in the absence of identified genetic mutations. Partial responses to treatments with plasma exchange, eculizumab, and rituximab were obtained, but the allograft was lost after 26 months. This case is the first report of concomitant FSGS and TMA in a renal transplant recipient. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect